Relay is excited to attend 2012 The Boston Biotech Business Development Conference The Boston Biotech Business Development Conference is a networking forum for industry professionals offering exclusive access to the key decision makers who influence deal making and investment in the life sciences. Attendees will gain insights from presentations and panels featuring business development decision-makers from …
Relay is excited to attend the Early-Stage Life Sciences Technology Conference VIII The Early-Stage Life Sciences Technology Conference VIII will showcase 20 life sciences technologies developed at the universities, research institutions, and hospitals of Massachusetts and recently formed Massachusetts companies to an audience of angel investors, venture capitalists and corporate investors. April 12, 2012, 1:00-7:00 pm Merck …
Relay will attend the Windhover Pharmaceutical Strategic Outlook from April 11-13 in New York City Topics discussed this year will include: Compensating the Dealmakers: “Am I Over or Underpaid?” Debate: The Runners and Riders in the Race for the Next Blockbuster More from Less: Optimizing the R&D Budget The Next Big Opportunity: Picking the Lottery …
Relay Technology Management is excited to attend the MassBio 2012 Annual Conference. The goals of the Annual Meeting are to Connect, Collaborate, and Innovate: 1. Discuss and debate the most relevant science and business topics driving industry’s innovation challenges 2. Promote collaboration with industry scientists, CSOs and other life sciences leaders to enhance scientific and …
Relay Technology Management will be exhibiting at BioEurope Spring from March 18-21st, 2012 in Amsterdam. Where the global biotech industry comes to partner BIO-Europe Spring is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featured speakers at BioEurope Spring: Vaughn Kailian …
Wednesday, February 1 2012 8:00 am – 10:00 am Location: MassBio, One Cambridge Center, 9th Floor, Cambridge With the patent cliff and a capital crisis, pharma companies large and small face increased performance pressures to ensure successful drug development. Yet, many people spend an entire career in drug development without ever seeing a single of their …
